69 results
Page 2 of 4
8-K
EX-99.1
o68gs u7v3y
11 May 23
Invivyd Reports First Quarter 2023 Financial Results and Business Highlights
4:08pm
8-K
EX-99.1
6ac0i38cq6bxsie7b8ny
2 May 23
Departure of Directors or Certain Officers
7:37am
8-K
EX-99.1
7sxs yyuro
6 Dec 22
Departure of Directors or Certain Officers
4:28pm
8-K
EX-99.1
3uyftu 8j
17 Nov 22
Invivyd Announces Partnership with Population Health Partners to Accelerate Clinical Development In Infectious Diseases Including COVID-19
7:10am
8-K
EX-99.1
zkn1xkn eq7zu
10 Nov 22
Invivyd Reports Third Quarter 2022 Financial Results and Business Highlights
4:13pm
8-K
EX-99.1
e3jcl89dit9w5zd7io
24 Oct 22
Invivyd Announces the Appointment of Christine Lindenboom to Board of Directors
4:30pm
8-K
EX-99.1
6m0 gxdht
13 Oct 22
Invivyd Appoints Fred Driscoll as Interim Chief Financial Officer and Announces Resource Reallocation to Maximize Integrated Discovery
4:16pm
S-3
r3sqq 5enl6gju0hg
28 Sep 22
Shelf registration
5:08pm
8-K
EX-99.1
vfd5qg4n
12 Sep 22
Adagio Therapeutics Announces Corporate Name Change to Invivyd
7:46am
8-K
EX-99.2
399fg8xj m7l9gl4lmn
12 Sep 22
Adagio Therapeutics Announces Corporate Name Change to Invivyd
7:46am
8-K
EX-99.3
60g8yf6c9vjci6
12 Sep 22
Adagio Therapeutics Announces Corporate Name Change to Invivyd
7:46am
8-K
EX-99.1
ewlwwckyriqt
15 Aug 22
Adagio Therapeutics Reports Second Quarter 2022 Financial Results and Business Highlights
7:22am
8-K
EX-99.1
gc8g8
5 Jul 22
Adagio Announces Results of Annual Meeting of Stockholders and Evolution of the Board of Directors
4:41pm
8-K
EX-99.2
12q94t93zhxia
5 Jul 22
Adagio Announces Results of Annual Meeting of Stockholders and Evolution of the Board of Directors
4:41pm
DEFC14C
on950wdzork638swo
2 Jun 22
Information statement in contested solicitation
4:24pm
PRER14C
mz8b92bvl1t
31 May 22
Preliminary revised information
5:09pm
PREC14C
hwkuw4nfv5s14 863dhi
19 May 22
Preliminary information statement in contested solicitation
5:05pm